Promis Neurosciences Inc. (PMN) — 10-Q Filings

10-Q Filings (6)

• ProMIS Neurosciences R&D Soars, Net Loss Widens to $29M — Nov 12, 2025 Risk: high
  ProMIS Neurosciences Inc. reported a significant net loss of $29,045,059 for the nine months ended September 30, 2025, a stark contrast to the net income of $3,
• ProMIS Neurosciences' Losses Mount Amid Soaring R&D Costs — Aug 13, 2025 Risk: high
  ProMIS Neurosciences Inc. (PMN) reported a significant increase in net loss for the three and six months ended June 30, 2025, reaching $10.1 million and $17.5 m
• ProMIS Neurosciences Files Q1 2025 10-Q — May 12, 2025 Risk: medium
  ProMIS Neurosciences Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as AMORFIX LIFE SCIENCES LTD, reported financial data
• ProMIS Neurosciences Q3 2024 Financials Revealed — Nov 14, 2024 Risk: medium
  ProMIS Neurosciences Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $32,689,190 and total liabilities of $18
• ProMIS Neurosciences Q2 2024 Update: Cash Stable, Warrant Data Detailed — Aug 8, 2024 Risk: medium
  ProMIS Neurosciences Inc. filed its 10-Q for the period ending June 30, 2024. The company reported cash and cash equivalents of $18.96 million as of June 30, 20
• ProMIS Neurosciences Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: medium
  ProMIS Neurosciences Inc. (PMN) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. ProMIS Neurosciences Inc. filed a 10-Q for the period ending March

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX